Mission Bio identifies $30m series B
Agilent and Lam Research participated in a $30m series B for UCSF's DNA analysis spinout Mission Bio, whose existing shareholders include Stanford-StartX Fund.
Axelspace explores $23m series B round
UTokyo Innovation Platform has backed a $22.8m investment round for Axelspace that will fund the launch of the Tokyo spinout's latest satellite.
Stanford helps EdCast curate fresh funding
The AI-based contextual insight service has closed a $33.6m round that included Stanford University, taking its total funding to almost $56m.
WaveOptics makes a splash with $26m
IP Group has backed AR technology developer WaveOptics, building on the position taken by Touchstone Innovations, which it now owns, in 2015 and 2017.
Firefly finds $21.5m spark
Previously backed by Stanford-StartX Fund, Firefly installs digital advertising screens on taxis to provide drivers with greater income and collect urban data for municipal authorities.
Tactiva takes $35m series A on board
Tactiva, an immuno-oncology spinout of Roswell Park Comprehensive Cancer Center and based at University of Buffalo, will use the funding to drive its development program.
24tidy cleans up with $30m series C
Xi'an Jiaotong University's foundation was among the investors in domestic services booking platform 24tidy as the company increased its total to at least $62.7m.
Fluidic Analytics characterises $31m
Cambridge Enterprise-backed Fluidic Analytics' third funding round will help fund the launch of its first microfluidics-based protein analysis machine.

Other News

Elens articulates $21.6m
Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.
University Ventures enrols in Unicaf’s latest round
Online higher education platform Unicaf has raised series B funding from a consortium also including Goldman Sachs, EdX and CDC Group as it gears up to target more students.
Amal Therapeutics amplifies series B round
Boehringer Ingelheim and Helsinn helped University of Geneva vaccine spinout Amal reach the second close of a series B round that now totals $32.7m.
Cabaletta Bio engineers $38m series A
Penn spinout Cabaletta Bio’s first funding round includes university investment and it will use the cash to develop T-cell drugs for autoimmune diseases including pemphigus vulgaris.
Ayar Labs lights up $24m series A
Ayar Labs has raised $24m to commercialise its technology that enables data transmission using light, based on research at MIT and CU Boulder.
LPixel captures $27m
Fujifilm, Olympus and TechMatrix were among the participants in a round that boosted medical imaging technology spinout LPixel's funding to $35m altogether.

Editor's Picks

Tel Aviv partners with Tata
Tel Aviv University announces $20m commercialisation fund with Tata Industries.
UK graphene research nets $35m backing
Cell Medica raises $26.5m
Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.
Revolymer sticks to AIM in IPO
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
test reg